Loading company…
QuantaBrain uses brain imaging analysis to develop biomarkers for psychiatric diagnosis and neurodevelopmental assessment.
QuantaBrain develops imaging-based biomarkers to support psychiatric diagnosis and personalized treatment. Its AI analyzes brain imaging, with a focus on autism spectrum disorder and identifying biomarkers in functional magnetic resonance imaging. Founded by CEO Elisa Ferrari, it is based in Italy. In September 2023, it received venture funding from Scientifica Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in